Innovative Treatment Offerings Genesis Biosystems develops advanced aesthetic devices like DermaFrac C and Dermacel Peel System, which appeal to skincare clinics and med-spas seeking cutting-edge, safe, and effective treatment options that require minimal patient downtime, opening opportunities to partner with providers looking to upgrade their service portfolios.

Growing Market Presence With a revenue range of up to 10 million dollars and a focus on skin rejuvenation, Genesis is positioned within the rapidly expanding medical aesthetic industry, presenting opportunities to target clinics and practitioners who are investing in innovative equipment to differentiate their practices.

Technology Adoption The company's use of advanced micro-needling and infusion technology, along with proprietary formulations, offers a compelling value proposition for clinics aiming to adopt the latest dermatological innovations, enabling sales of complementary products such as topical infusion solutions and peel systems.

Customer Expandability Genesis Biosystems’ focus on safe, predictable, and effective treatments suitable for all skin types makes their offerings accessible to a wide range of skincare providers, including dermatologists and clinics seeking reliable, non-invasive procedures to grow their patient base.

Upcoming Opportunities The recent launch of Dermacel and ongoing product innovation indicate opportunities for account expansion through offering related skincare protocols, training, and complementary devices, especially in markets where aesthetic clinics are expanding services to include advanced skin resurfacing and rejuvenation treatments.